Abstract
Diabetes increases the risk of occurrence and poor functional recovery after ischemic stroke injury. Previously, we have demonstrated greater hemorrhagic transformation (HT), edema, and more severe functional deficits after stroke in diabetic animals that also presented with cerebral vasoregression and endothelial cell death in the recovery period. Given that Toll-like receptor 4 (TLR-4) activation in microvascular endothelial cells triggers a robust inflammatory response, we hypothesized that inhibition of TLR-4 signaling prevents endothelial cell death and improves outcomes after stroke. Animals were treated with vehicle or TLR-4 inhibitor TAK242 (3 mg/kg; i.p.) following middle cerebral artery occlusion (MCAO). Neurobehavioral deficits were measured at baseline and day 3 after ischemic stroke. Primary brain microvascular endothelial cells (BMVECs) from diabetic animals were subjected to oxygen glucose deprivation re-oxygenation (OGDR) and treated with 0.1 mM iron(III)sulfate hydrate (iron) (to mimic the post-stroke bleeding) and TLR-4 inhibitors. Ischemic stroke increased the expression of TLR-4 in both hemispheres and in the microvasculature of diabetic animals. Cerebral infarct, edema, HT, and functional deficits were greater in diabetic compared to control animals. Inhibition of TLR-4 significantly reduced the neurovascular injury and improved functional outcomes. OGDR and iron reduced the cell viability and increased the expression of TLR-4 associated proteins (RIP3, MyD88, phospho-NF-kB, and release of IL-6) in BMVECs from diabetic animals. In conclusion, TLR-4 is highly upregulated in the microvasculature and that beneficial effects of TLR-4 inhibition are more profound in diabetes. This suggests that inhibition of vascular TLR-4 may provide therapeutic benefits for stroke recovery in diabetes.
Similar content being viewed by others
References
Krishnamurthi RV, Moran AE, Feigin VL, Barker-Collo S, Norrving B, Mensah GA, Taylor S, Naghavi M et al (2015) Stroke prevalence, mortality and disability-adjusted life years in adults aged 20-64 years in 1990-2013: data from the global burden of disease 2013 study. Neuroepidemiol 45(3):190–202. https://doi.org/10.1159/000441098
Ergul A, Kelly-Cobbs A, Abdalla M, Fagan SC (2012) Cerebrovascular complications of diabetes: focus on stroke. Endocr Metab Immune Disord Drug Targets 12(2):148–158
Navaratna D, Guo S, Arai K, Lo EH (2009) Mechanisms and targets for angiogenic therapy after stroke. Cell Adhes Migr 3(2):216–223
Xiong Y, Mahmood A, Chopp M (2010) Angiogenesis, neurogenesis and brain recovery of function following injury. Current Opin Investig Drugs 11(3):298–308
Ergul A, Alhusban A, Fagan SC (2012) Angiogeneis: a harmonized target for recovery after stroke. Stroke 43(8):2270–2274. https://doi.org/10.1161/STROKEAHA.111.642710
Prakash R, Somanath PR, El-Remessy AB, Kelly-Cobbs A, Stern JE, Dore-Duffy P, Johnson M, Fagan SC et al (2012) Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes 61(6):1533–1542. https://doi.org/10.2337/db11-1528
Abdelsaid M, Prakash R, Li W, Coucha M, Hafez S, Johnson MH, Fagan SC, Ergul A (2015) Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes. Diabetes 64(5):1804–1817. https://doi.org/10.2337/db14-1423
Babu R, Bagley JH, Di C, Friedman AH, Adamson C (2012) Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. Neurosurg Focus 32(4):E8. https://doi.org/10.3171/2012.1.FOCUS11366
Robinson SR, Dang TN, Dringen R, Bishop GM (2009) Hemin toxicity: a preventable source of brain damage following hemorrhagic stroke. Redox Rep 14(6):228–235. https://doi.org/10.1179/135100009X12525712409931
Hua F, Tang H, Wang J, Prunty MC, Hua X, Sayeed I, Stein DG (2015) TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. J Cereb Blood Flow Metab 35(4):536–542. https://doi.org/10.1038/jcbfm.2014.240
Hyakkoku K, Hamanaka J, Tsuruma K, Shimazawa M, Tanaka H, Uematsu S, Akira S, Inagaki N et al (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171(1):258–267. https://doi.org/10.1016/j.neuroscience.2010.08.054
Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115(12):1599–1608. https://doi.org/10.1161/CIRCULATIONAHA.106.603431
Ning R, Chopp M, Yan T, Zacharek A, Zhang C, Roberts C, Cui X, Lu M et al (2012) Tissue plasminogen activator treatment of stroke in type-1 diabetes rats. Neuroscience 222:326–332. https://doi.org/10.1016/j.neuroscience.2012.07.018
Rodriguez-Yanez M, Brea D, Arias S, Blanco M, Pumar JM, Castillo J, Sobrino T (2012) Increased expression of Toll-like receptors 2 and 4 is associated with poor outcome in intracerebral hemorrhage. J Neuroimmunol 247(1–2):75–80. https://doi.org/10.1016/j.jneuroim.2012.03.019
Lu Z, Li Y, Jin J, Zhang X, Lopes-Virella MF, Huang Y (2012) Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler Thromb Vasc Biol 32(7):1696–1706. https://doi.org/10.1161/ATVBAHA.112.251181
Li C, Che LH, Ji TF, Shi L, Yu JL (2017) Effects of the TLR4 signaling pathway on apoptosis of neuronal cells in diabetes mellitus complicated with cerebral infarction in a rat model. Sci Rep 7:43834. https://doi.org/10.1038/srep43834
Ergul A, Elgebaly MM, Middlemore ML, Li W, Elewa H, Switzer JA, Hall C, Kozak A et al (2007) Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol 7:33. https://doi.org/10.1186/1471-2377-7-33
Kelly-Cobbs AI, Prakash R, Li W, Pillai B, Hafez S, Coucha M, Johnson MH, Ogbi SN et al (2013) Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes. Am J Physiol Heart Circ Physiol 304(6):H806–H815. https://doi.org/10.1152/ajpheart.00720.2012
Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, Xi G (2007) Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke 38(4):1362–1367. https://doi.org/10.1161/01.STR.0000259660.62865.eb
Prakash R, Li W, Qu Z, Johnson MA, Fagan SC, Ergul A (2013) Vascularization pattern after ischemic stroke is different in control versus diabetic rats: Relevance to stroke recovery. Stroke 44(10):2875–2882. https://doi.org/10.1161/STROKEAHA.113.001660
Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP (2004) Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res 1027(1–2):48–58. https://doi.org/10.1016/j.brainres.2004.08.043
Prakash R, Johnson M, Fagan SC, Ergul A (2013) Cerebral neovascularization and remodeling patterns in two models of type 2 diabetes. PLoS One 8(2):e56264
Lockman JA, Geldenhuys WJ, Bohn KA, Desilva SF, Allen DD, Van der Schyf CJ (2007) Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types. Neurochem Res 37:134–142
Othman A, Ahmad S, Megyerdi S, Mussell R, Choksi K, Maddipati KR, Elmarakby A, Rizk N et al (2013) 12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase. PLoS One 8(2):e57254. https://doi.org/10.1371/journal.pone.0057254
Abdelsaid MA, Matragoon S, El-Remessy AB (2013) Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells. Antioxid Redox Signal 19(18):2199–2212. https://doi.org/10.1089/ars.2012.4761
Lim KH, Staudt LM (2013) Toll-like receptor signaling. Cold Spring Harb Perspect Biol 5(1):a011247. https://doi.org/10.1101/cshperspect.a011247
Elgebaly MM, Prakash R, Li W, Ogbi S, Johnson MH, Mezzetti EM, Fagan SC, Ergul A (2010) Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. J Cereb Blood Flow Metab 30(12):1928–1938. https://doi.org/10.1038/jcbfm.2010.120
Knoflach M, Matosevic B, Rucker M, Furtner M, Mair A, Wille G, Zangerle A, Werner P et al (2012) Functional recovery after ischemic stroke—a matter of age: data from the Austrian Stroke Unit Registry. Neurology 78(4):279–285. https://doi.org/10.1212/WNL.0b013e31824367ab
Baird TA, Parsons MW, Phan T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR et al (2003) Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34(9):2208–2214. https://doi.org/10.1161/01.STR.0000085087.41330.FF
Gorelick PB, Furie KL, Iadecola C, Smith EE, Waddy SP, Lloyd-Jones DM, Bae HJ, Bauman MA et al (2017) Defining optimal brain health in adults: a presidential advisory from the American Heart Association/American Stroke Association. Stroke 48(10):e284–e303. https://doi.org/10.1161/STR.0000000000000148
Iadecola C (2017) The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 96(1):17–42. https://doi.org/10.1016/j.neuron.2017.07.030
Xi G, Keep RF, Hoff JT (2006) Mechanisms of brain injury after intracerebral haemorrhage. The Lancet Neurol 5(1):53–63. https://doi.org/10.1016/S1474-4422(05)70283-0
Aronowski J, Zhao X (2011) Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke 42(6):1781–1786. https://doi.org/10.1161/STROKEAHA.110.596718
Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL et al (2007) Characterization of heme as activator of Toll-like receptor 4. J Biol Chem 282(28):20221–20229. https://doi.org/10.1074/jbc.M610737200
Belcher JD, Chen C, Nguyen J, Milbauer L, Abdulla F, Alayash AI, Smith A, Nath KA et al (2014) Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 123(3):377–390. https://doi.org/10.1182/blood-2013-04-495887
Belcher JD, Nath KA, Vercellotti GM (2013, 2013) Vasculotoxic and proinflammatory effects of plasma heme: cell signaling and cytoprotective responses. ISRN Oxidative Med:831596. https://doi.org/10.1155/2013/831596
Funk SD, Yurdagul A Jr, Orr AW (2012) Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med 2012:569654–569619. https://doi.org/10.1155/2012/569654
Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7):499–511. https://doi.org/10.1038/nri1391
Cole JE, Mitra AT, Monaco C (2010) Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets. Expert Rev Cardiovasc Ther 8(11):1619–1635. https://doi.org/10.1586/erc.10.149
Acknowledgements
AE is a Research Career Scientist at the Charlie Norwood Veterans Affairs Medical Center in Augusta, GA. This work was supported in part by a Veterans Affairs (VA) Merit Award (BX000347), VA Research Career Scientist Award and National Institutes of Health (NIH) awards (R01NS083559) to AE and Program Project award (PO1HL128207) to RCW, JCS, and AE. The contents do not represent the views of the Department of Veterans Affairs or the US Government.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
ESM 1
(PPTX 2764 kb)
Rights and permissions
About this article
Cite this article
Abdul, Y., Abdelsaid, M., Li, W. et al. Inhibition of Toll-Like Receptor-4 (TLR-4) Improves Neurobehavioral Outcomes After Acute Ischemic Stroke in Diabetic Rats: Possible Role of Vascular Endothelial TLR-4. Mol Neurobiol 56, 1607–1617 (2019). https://doi.org/10.1007/s12035-018-1184-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-018-1184-8